MOBILion Systems to Showcase Groundbreaking Advances in Proteomics
MOBILion Systems, Inc. is set to make a significant impact at the upcoming Human Proteome Organization (HUPO) World Congress. This event provides a platform for the company to showcase its state-of-the-art PAMAF™ technology, which is designed to enhance proteomics sensitivity while effectively increasing throughput.
Revolutionizing Proteomics with PAMAF Technology
The core of MOBILion's advancements lies in its Parallel Accumulation Mobility Aligned Fragmentation (PAMAF™) technology. This innovative method promises considerable improvements in mass spectrometry (MS) sensitivity and workflow efficiency, particularly beneficial in the realms of proteomics and multi-omics research. According to Daniel DeBord, the Chief Technology Officer, PAMAF technology facilitates near-complete ion utilization, which is crucial for in-depth proteome analysis.
Addressing the Challenges of Modern Proteomics
Post-translational modifications (PTMs) and proteoforms are increasingly recognized as vital components in clinical diagnostics and drug development. MOBILion's PAMAF technology, supported by High-Resolution Ion Mobility (HRIM), not only improves the depth of detection but also enhances the reliability of results. This innovation overcomes the limitations of traditional quadrupole filtering techniques, achieving up to 500 Hz spectral generation rates. Such technological advancements ensure that researchers can maximize ion detection efficiency and amplify the intensity of MS signals.
Impact on Research and Therapeutics
Melissa Sherman, CEO of MOBILion Systems, emphasized the implications of PAMAF technology in real-world applications. The improvement in fragment ion intensity has been observed to soar between 300–2,000%, significantly boosting identification rates of proteins and PTMs. Such remarkable enhancements are pivotal for researchers aiming to discover new biomarker potentials and therapeutic options. This means scientists can work with smaller sample sizes while identifying a broader spectrum of proteins, ultimately leading to groundbreaking advancements in the fields of proteomics and health care.
Key Findings from the Recent Research
During the HUPO 2025 congress, DeBord plans to present compelling benchmark data derived from LC-HRIM-MS experiments involving the MOBIE® HRIM module integrated with an existing QTOF platform. With the utilization of PAMAF mode, results have shown transformative improvements such as a remarkable 100-fold increase in fragment ion intensity, 3-12 times more identified protein groups, and a 43-53% rise in peptide counts per protein within cell line digests.
Advancing Proteomics Research with Enhanced Ion Utilization
Insights shared by DeBord highlight the critical role of improved ion utilization in mass spectrometry. By doing away with traditional quadrupole filtering, PAMAF aligns fragmentation processes with ion mobility—a strategy that paves the way for more comprehensive analyses of complex biological samples. This innovative approach brings scientists closer to achieving an extensive overview of proteome and proteoform data.
Commitment to Innovative Approaches
MOBILion Systems' participation in HUPO 2025 underscores its dedication to enhancing proteomics measurement capabilities. The company remains committed to pushing the boundaries of separation science to ultimately refine the processes and methodologies utilized in life sciences, thereby making significant contributions to the fields of clinical diagnostics and therapeutic development.
About MOBILion Systems, Inc.
MOBILion Systems focuses on developing high-performance analytical tools that unveil undetected molecular insights by incorporating Structures for Lossless Ion Manipulation (SLIM) technology. Their proprietary High-Resolution Ion Mobility (HRIM) technology enhances sensitivity, throughput, and separation power across various applications including proteomics, lipidomics, and metabolomics. The mission of MOBILion is to empower researchers in accelerating their discoveries while fostering precision medicine approaches.
Frequently Asked Questions
What is PAMAF technology?
PAMAF stands for Parallel Accumulation Mobility Aligned Fragmentation, a technique developed by MOBILion to improve mass spectrometry sensitivity and efficiency.
How does PAMAF impact proteomics research?
PAMAF enhances ion utilization, leading to higher fragment ion intensity and increased identification rates of proteins and post-translational modifications.
What advancements does MOBILion Systems bring?
MOBILion Systems innovates in separation science, offering tools that reveal complex molecular details critical for advancing drug development and clinical diagnostics.
Where will MOBILion present its findings?
MOBILion will present at the Human Proteome Organization World Congress in Toronto, showcasing its technological advancements.
What does MOBILion's technology enable researchers to do?
The technology allows researchers to analyze smaller sample sizes while identifying a greater number of proteins, thus facilitating new discoveries in human health and disease.
